Showing results (911-920 of 5,480) with videos related to
Sort By:
Pageof 548
Pharmacotherapy|June 2, 2005
Peak antifactor xa activity produced by dalteparin treatment in patients with renal impairment compared with controlsAdam R Shprecher, Angela Cheng-Lai, Eileen M Madsen, et al.Pharmacotherapy|June 2, 2005
Aspirin under fire: aspirin use in the primary prevention of coronary heart diseaseMichael G Miller, B Daniel Lucas, Vasilios Papademetriou, et al.Pharmacotherapy|June 2, 2005
Life-threatening hemorrhage after dalteparin therapy in a patient with impaired renal functionSabin S Egger, Mikael G Sawatzki, Jürgen Drewe, et al.Pharmacotherapy|July 26, 2006
ST-segment-elevation myocardial infarction: guidelines and the challenge of real-world patient careSarah A SpinlerPharmacotherapy|July 26, 2006
Tigecycline: first of a new class of antimicrobial agentsWarren E Rose, Michael J RybakPharmacotherapy|July 26, 2006
Atypical warfarin-induced skin necrosisCeressa T Ward, Nann ChavalitanondaPharmacotherapy|July 26, 2006
Olanzapine-associated neuroleptic malignant syndromeNick B Norgard, Jennifer E StarkPharmacotherapy|September 1, 1993
Assessing the treatment of congestive heart failure: inotropic agents and calcium channel blockersD E HillemanPharmacotherapy|January 1, 1994
Angioedema and urticaria associated with omeprazole confirmed by drug rechallengeH A Bowlby, G R DickensPharmacotherapy|January 1, 1994
Venous irritation related to intravenous administration of phenytoin versus fosphenytoinB D Jamerson, G E Dukes, K L Brouwer, et al.Pageof 548